Editorial Board

Editor-in-Chief

  • Alex A. Adjei, MD, PhD, FACP, Taussig Cancer Institute, Cleveland, Ohio, United States of America, Area of expertise - Medical oncology,  Clinical pharmacology,  Drug development,  Translational research

Associate Editors

  • Joachim G. Aerts, MD, PhD, Erasmus Medical Center, Rotterdam, Netherlands, Area of expertise – Thoracic oncology,  Clinical and Translational research
  • Surein Arulananda, MBBS, PhD, Monash Health, Clayton, Australia, Thoracic oncology,  Clinical and translational research,  Basic science
  • Anne-Marie Baird, PhD, Trinity College Dublin School of Medicine, Dublin, Ireland, Area of expertise – Basic Research,  Clinical research
  • Jeffrey Bogart, MD, SUNY Upstate Medical University, Syracuse, New York, United States of America, Area of expertise - Radiation oncology,  Clinical research
  • Lukas Bubendorf, MD, University of Basel, Basel, Switzerland, Area of expertise – Pathology,  Cytopathology,  Translational research
  • D. Ross Camidge, MD, PhD, University of Colorado - Anschutz Medical Campus, Aurora, Colorado, United States of America, Area of expertise - Medical oncology,  Clinical pharmacology,  Drug development,  Translational research
  • Haiquan Chen, MD, PhD, Fudan University Shanghai Cancer Center, Shanghai, China, Area of expertise - Thoracic Surgical Oncology,  Clinical and Basic Research
  • Wendy Cooper, BScMed(Hons), MBBS(Hons), PhD, FFSc(RCPA), FRCPA, Royal Prince Alfred Hospital, Department of Tissue Pathology and Diagnostic Oncology, Camperdown, Australia, Pathology,  Biomarkers
  • Afshin Dowlati, MD, Case Western Reserve University, Cleveland, Ohio, United States of America, Area of Expertise - Biology of thoracic cancers,  Preclinical drug development,  Early phase clinical trials,  Small cell lung cancer
  • Enriqueta Felip, MD, Vall d'Hebron University Hospital, Barcelona, Spain, Area of expertise – Medical oncology,  Clinical and Translational research
  • Cheryl Ho, MD, FRCPC, British Columbia Cancer Agency, Vancouver, British Columbia, Canada, Area of expertise - Medical oncology,  Population-based research
  • Satoshi Ishikura, MD, PhD, Tokyo Bay Makuhari Clinic for Advanced Imaging, Cancer Screening, and High-Precision Radiotherapy, Chiba, Japan, Area of expertise - Radiation oncology,  Concurrent chemoradiotherapy,  Radiation techniques,  Intensity-modulated radiotherapy (IMRT),  Stereotactic body radiation therapy (SBRT),  Quality assurance of radiotherapy
  • Thomas John, M.B.B.S., PhD, FRACP, Peter MacCallum Cancer Centre, Melbourne, Australia, Area of expertise - Thoracic oncology,  Familial cancers,  Clinical trials,  Translational research,  Cancer biology,  Molecular research
  • Keith Kerr, BSc, MB ChB, FRCPath, FRCPEd, FFPath(RCPI), University of Aberdeen School of Medical Sciences, Aberdeen, United Kingdom, Thoracic pathology,  Thoracic cancers,  Biomarkers,  EGFR,  Fluorescence in situ hybridisation,  Immunohistochemistry,  KRAS,  Multiplex mutation analysis,  Next-generation sequencing,  Non small cell lung cancer,  PD-L1
  • Chee Khoon Lee, MBBS (Hons), MMedSci (Clin Epid), MBiostat, FRACP, PhD, The University of Sydney, Sydney, New South Wales, Australia, Area of expertise – EGFR mutant non-small cell lung cancer,  Biostatistics
  • Shun Lu, MD, PhD, Shanghai Jiao Tong University Affiliated Chest Hospital, Shanghai, China, Area of expertise - Medical oncology,  Drug development,  Translational research
  • Sumithra J. Mandrekar, PhD, Mayo Clinic Rochester, Rochester, Minnesota, United States of America, Area of expertise - Biostatistics,  Clinical Trials
  • Luis Montuenga, PhD, University of Navarra, Pamplona, Spain, Area of expertise - Basic sciences,  Translational research
  • Silvia Novello, MD, PhD, University of Turin, Torino, Italy, Area of expertise - Medical oncology,  Drug development,  Translational research,  Patient advocacy
  • Sai-Hong Ignatius Ou, MD, PhD, University of California Irvine, Irvine, California, United States of America, Area of expertise - Nasopharyngeal Carcinoma,  Head and Neck Cancer,  Thoracic malignancies,  Esophageal carcinoma,  Targeted therapy
  • Keunchil Park, MD, PhD, Samsung Medical Center, Department of Anesthesiology and Pain Medicine, Seoul, South Korea, Area of expertise - Medical oncology,  Clinical and translational research
  • Jean-Louis Pujol, MD, PhD, University Hospital Centre Montpellier, Montpellier, France, Area of expertise - Thoracic Oncology,  Methodology of clinical trial clinical,  Translational research,  Psycho-oncology
  • Anja C. Roden, MD, Mayo Clinic Rochester, Rochester, Minnesota, United States of America, Area of expertise – Thoracic pathology,  Surgical pathology
  • Ross Soo, MBBS, PhD, FRACP, National University Cancer Institute, Singapore, Singapore, Area of Expertise - Medical oncology,  early phase studies,  Clinical and translational research
  • Gabriella Sozzi, PhD, National Cancer Institute IRCCS Pascale Foundation, Napoli, Italy, Area of expertise - Basic science,  Translational research,  Molecular biology,  Genetics
  • Emily Stone, MBBS, PhD, FRACP, St Vincent's Hospital Sydney, Darlinghurst, Australia, Area of expertise - Respiratory medicine,  Multidisciplinary team care,  Tobacco control and smoking cessation,  Translational research
  • Shinichi Toyooka, MD, PhD, Okayama University, Okayama, Japan, Area of expertise - Surgery,  Translational research
  • William Travis, MD, Memorial Sloan Kettering Cancer Center, New York, New York, United States of America, Area of expertise - Thoracic pathology,  Lung cancer,  Malignant mesothelioma,  Thymic tumors,  Staging
  • Paul Van Schil, MD, PhD, University Hospital Antwerp, Edegem, Belgium, Area of expertise - Thoracic oncology,  Thoracic surgery
  • Graham Warren, MD, PhD, Medical University of South Carolina, Charleston, South Carolina, United States of America, Area of expertise - Radiation oncology,  Tobacco use,  Epidemiology,  Patient outcomes,  Translational research
  • James Chih-Hsin Yang, MD, PhD, National Taiwan University College of Medicine, Taipei, Taiwan, Area of expertise - Medical oncology,  Drug development,  Translational research,  Cancer therapy resistance research
  • Yasushi Yatabe, MD, PhD, National Cancer Center Japan, Chuo-Ku, Japan, Area of expertise - Diagnostic Pathology,  Molecular Pathology,  Translational research
  • Junji Yoshida, MD, PhD, Tokyo Midtown Medicine Co Ltd, Minato-Ku, Japan, Area of expertise - Chest surgery,  Thoracic malignancy

Publication Staff

Managing Editor

  • Mary S. Todd

Editorial Consultant

  • Vun-Sin Lim, PhD